Ohmiya M - Search Results

1

Long term survey of hepatitis C virus infection in hemodialysis units in Fukuoka, Japan.

Yamaji K, Hayashi J, Kawakami Y, Yoshimura E, Kishihara Y, Ohmiya M, Etoh Y, Kashiwagi S. Yamaji K, et al. Among authors: ohmiya m. J Epidemiol. 1996 Dec;6(4):166-71. doi: 10.2188/jea.6.166. J Epidemiol. 1996. PMID: 9002381 Free article.

2

Prevalence and role of hepatitis C viraemia in haemodialysis patients in Japan.

Hayashi J, Nakashima K, Yoshimura E, Kishihara Y, Ohmiya M, Hirata M, Kashiwagi S. Hayashi J, et al. Among authors: ohmiya m. J Infect. 1994 May;28(3):271-7. doi: 10.1016/s0163-4453(94)91743-4. J Infect. 1994. PMID: 7522260

3

Inverse correlation between the titre of antibody to hepatitis C virus and the degree of hepatitis C viraemia.

Yoshimura E, Hayashi J, Tani Y, Ohmiya M, Nakashima K, Ikematsu H, Kinukawa N, Maeda Y, Kashiwagi S. Yoshimura E, et al. Among authors: ohmiya m. J Infect. 1994 Sep;29(2):147-55. doi: 10.1016/s0163-4453(94)90626-2. J Infect. 1994. PMID: 7528759

4

A preliminary study of retreatment of chronic hepatitis C with interferon.

Kishihara Y, Hayashi J, Ohmiya M, Nakashima K, Ikematsu H, Kashiwagi S. Kishihara Y, et al. Among authors: ohmiya m. Fukuoka Igaku Zasshi. 1995 Apr;86(4):113-20. Fukuoka Igaku Zasshi. 1995. PMID: 7782023 Clinical Trial.

5

Elevation of serum soluble interleukin-2 receptor levels in patients with hepatitis C virus infection.

Kawakami Y, Hayashi J, Ueno K, Ohmiya M, Kishihara Y, Yamaji K, Kashiwagi S. Kawakami Y, et al. Among authors: ohmiya m. Fukuoka Igaku Zasshi. 1997 Jul;88(7):274-82. Fukuoka Igaku Zasshi. 1997. PMID: 9267073

6

Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease.

Hayashi J, Nakashima K, Kishihara Y, Ohmiya M, Yoshimura E, Hirata M, Kashiwagi S. Hayashi J, et al. Among authors: ohmiya m. J Infect. 1993 May;26(3):287-94. doi: 10.1016/0163-4453(93)95443-m. J Infect. 1993. PMID: 7685043

7

Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.

Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Ohmiya M, Tani Y, Ikematsu H, Kashiwagi S. Hayashi J, et al. Among authors: ohmiya m. Dig Dis Sci. 1995 Aug;40(8):1837-41. doi: 10.1007/BF02212710. Dig Dis Sci. 1995. PMID: 7648988

8

A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C.

Hayashi J, Ohmiya M, Kishihara Y, Tani Y, Kinukawa N, Ikematsu H, Kashiwagi S. Hayashi J, et al. Among authors: ohmiya m. Am J Gastroenterol. 1994 Dec;89(12):2151-6. Am J Gastroenterol. 1994. PMID: 7977232 Clinical Trial.

9

Large dose natural interferon alpha therapy for patients with chronic hepatitis C.

Ohmiya M, Hayashi J, Furusyo N, Ueno K, Kishihara Y, Nabeshima S, Kashiwagi S. Ohmiya M, et al. Fukuoka Igaku Zasshi. 1997 Dec;88(12):380-8. Fukuoka Igaku Zasshi. 1997. PMID: 9465478 Clinical Trial.

10

Differences between interferon-alpha and -beta treatment for patients with chronic hepatitis C virus infection.

Furusyo N, Hayashi J, Ohmiya M, Sawayama Y, Kawakami Y, Ariyama I, Kinukawa N, Kashiwagi S. Furusyo N, et al. Among authors: ohmiya m. Dig Dis Sci. 1999 Mar;44(3):608-17. doi: 10.1023/a:1026625928117. Dig Dis Sci. 1999. PMID: 10080158 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters